Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Analgesic profile of new Ibuprofen lozenges in acute sore throat pain
2011-005848-10Phase 2Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of flurbiprofen in acute pharyngitis and tonsillopharyngitis (4 arms), sponsored by Pierre Fabre Laboratories. Primary endpoint: Change from baseline in sore throat pain intensity at 60 minutes. Started Dec 2011; status: completed.
02
Drugs
flurbiprofen
03
Conditions
acute pharyngitistonsillopharyngitis
Beyond the preview
Go deeper on 2011-005848-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005848-10.